GBM can be classified into three groups depending on the status of the isocitrate dehydrogenase (IDH) gene: IDH wild-type GBM, which represents about 90% of cases, mutated IDH, or not specified GBM (NOS, unevaluated status). The gene discussed is IDH3A; the disease is glioblastoma.